Skip to content

Senofilcon A Investigational Manufacturing Process

Clinical Investigation of Senofilcon A Manufactured Using an Alternate Hydration Process

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01951703
Enrollment
136
Registered
2013-09-27
Start date
2013-09-30
Completion date
2013-12-31
Last updated
2018-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comfort, Overall Vision, Visual Acuity

Brief summary

To evaluate the impact of a new contact lens hydration process

Detailed description

To evaluate the impact on clinical performance of senofilcon A lenses manufactured using an alternate hydration process and compare the performance with senofilcon A lenses manufactured using the current process.

Interventions

DEVICEsenofilcon A

Control, senfilcon A

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form. * The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol. * The subject must be at least 18 and not more than 70 years of age. * The subject's refractive cylinder must be \< 0.75D in each eye. * The subject must have best corrected visual acuity of 20/25 or better in each eye. * The subject must demonstrate adequate mobility and 20/30 vision OD and OS with the study contact lenses. * The subject must be a habitual and adapted wearer of ACUVUE® OASYS® Brand contact lens in both eyes. * The subject must have normal eyes (i.e., no ocular medications or infections of any type). * The subject's required spherical contact lens prescription must be in the range of -0.50 to -9.00D in each eye.

Exclusion criteria

* Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued). * Any ocular or systemic allergies or diseases that may interfere with contact lens wear. * Any systemic disease, autoimmune disease, or use of medication, that may interfere with contact lens wear. * Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or moderate or above corneal distortion by keratometry. * Any previous, or planned, ocular or interocular surgery (e.g., radial keratotomy, PRK, LASIK, etc.). * Any grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA classification scale, any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar), or any other ocular abnormality that may contraindicate contact lens wear. * Any known hypersensitivity or allergic reaction to OPTI-FREE® PureMoist® Contact Lens Solution. * Any ocular infection. * Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear. * Monovision or multi-focal contact lens correction. * Participation in any contact lens or lens care product clinical trial within 14 days prior to study enrollment. * History of binocular vision abnormality or strabismus. * Any infectious disease (e.g., hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g., HIV, by self report). * Suspicion of or recent history of alcohol or substance abuse. * History of serious mental illness. * History of seizures. * Employee of investigational clinic (e.g., Investigator, Coordinator, Technician)

Design outcomes

Primary

MeasureTime frameDescription
Subjective Overall Comfort (Using CLUE )2 weeksContact Lens User Experience Comfort scores (CLUE) is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.
Subjective Overall Vision (Using CLUE )2 weeksContact Lens User Experience Vision scores (CLUE) is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.

Countries

United States

Participant flow

Pre-assignment details

A total of 136 subjects were enrolled in the study; 9 subjects did not meet the inclusion and exclusion criteria and not randomized. Of the 127 randomized subjects, 6 were prematurely discontinued from the study and 2 were excluded from the analysis due to major protocol deviations.

Participants by arm

ArmCount
Control/Test
Subjects who received Control lens, senofilcon A for the first two weeks of the study and then received Test lens, senofilcon A in the last two weeks of the study.
64
Test/Control
Subjects who received Test lens, senofilcon A for the first two weeks of the study and then received Control lens, senofilcon A in the last two weeks of the study.
63
Total127

Withdrawals & dropouts

PeriodReasonFG000FG001
First InterventionPhysician Decision10
First InterventionSubject was not compliant11
First InterventionWithdrawal by Subject10
Second InterventionProtocol Violation01
Second InterventionUnsatisfactory Lens fitting01

Baseline characteristics

CharacteristicTotalControl/TestTest/Control
Age, Categorical
<=18 years
2 Participants2 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
125 Participants62 Participants63 Participants
Age, Continuous35.2 years
STANDARD_DEVIATION 9.6
35.5 years
STANDARD_DEVIATION 9.73
35.0 years
STANDARD_DEVIATION 9.63
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
4 Participants1 Participants3 Participants
Race (NIH/OMB)
Black or African American
5 Participants2 Participants3 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
117 Participants61 Participants56 Participants
Region of Enrollment
United States
127 participants64 participants63 participants
Sex: Female, Male
Female
102 Participants52 Participants50 Participants
Sex: Female, Male
Male
25 Participants12 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 640 / 63
serious
Total, serious adverse events
0 / 640 / 63

Outcome results

Primary

Subjective Overall Comfort (Using CLUE )

Contact Lens User Experience Comfort scores (CLUE) is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.

Time frame: 2 weeks

Population: Includes all subjects who completed all visits and did not have any major protocol deviation impacting the primary outcomes

ArmMeasureValue (MEAN)Dispersion
Control, Senofilcon ASubjective Overall Comfort (Using CLUE )63.3 units on a scaleStandard Deviation 24.85
Test, Senofilcon ASubjective Overall Comfort (Using CLUE )65.0 units on a scaleStandard Deviation 26.75
Primary

Subjective Overall Vision (Using CLUE )

Contact Lens User Experience Vision scores (CLUE) is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.

Time frame: 2 weeks

Population: Includes all subjects who completed all visits and did not have any major protocol deviation impacting the primary outcomes

ArmMeasureValue (MEAN)Dispersion
Control, Senofilcon ASubjective Overall Vision (Using CLUE )65.2 units on a scaleStandard Deviation 20.75
Test, Senofilcon ASubjective Overall Vision (Using CLUE )65.2 units on a scaleStandard Deviation 20.12

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026